Please Wait.....
Report
Neurosurgery Devices Market By Product (Neurostimulation Devices, Neurointerventional Devices, Neurosurgical Navigation Systems, Cerebral Spinal Fluid (CSF) Management Devices, Others) , By Application (Spinal Cord Stimulation, Deep Brain Stimulation, Neuroendoscopy) By End User (Hospitals, Ambulatory Surgical Centers, Others) : Global Opportunity Analysis and Industry Forecast, 2024-2033
Market Report I 2024-10-01 I 280 Pages I Allied Market Research
The neurosurgery devices market was valued at $11.9 billion in 2023, and is projected to reach $34.5 billion by 2033, growing at a CAGR of 11.3% from 2024 to 2033.
Neurosurgery devices are specialized medical equipment designed for diagnosing, monitoring, and treating disorders within the central and peripheral nervous systems, particularly in surgical procedures involving the brain, spinal cord, and nerves. These devices play a crucial role in managing neurological conditions such as brain tumors, aneurysms, traumatic brain injuries, and spinal cord injuries.
Alarming rise in prevalence of neurological disorders such as brain tumors, epilepsy, Parkinson's disease, and spinal cord injuries and surge in need for advanced surgical tools act as the key driving forces of the global neurosurgery devices market. A 2024 study published by the World Health Organization reported that more than 3 billion worldwide are suffering from neurological condition. Furthermore, surge in geriatric population significantly contributes toward the growth of the global market. This is attributed to the fact that as people age, neurons in the brain and nervous system can gradually deteriorate and lose functionality, and thus they become more susceptible to age-related neurological disorders such as Alzheimer's and Parkinson's. . As per the World Health Organization, the number of people aged 60 years and older was 1 billion in 2019. This number is estimated to increase to 1.4 billion by 2030 and 2.1 billion by 2050. Moreover, improvement in healthcare infrastructure, increase in investments in medical technology, and higher availability of neurosurgical facilities are the key factors supporting the global market growth. Furthermore, increase in funding for neurological research and healthcare subsidies are aiding in the development and adoption of neurosurgery devices, thereby augmenting the market growth. However, high cost associated with advanced neurosurgery devices, such as robotic surgical systems, imaging equipment, and high-precision tools, restrains the market growth. In addition, dearth of skilled neurosurgeons to operate advanced devices acts as the key deterrent factor of the market. On the contrary, innovations in imaging, robotic assistance, and minimally invasive techniques are enhancing the precision, safety, and efficiency of neurosurgical procedures. Such developments are expected to offer lucrative opportunities for the expansion of the global market during the forecast period.
The global neurosurgery devices industry is segmented into product, application, end user, and region. By product, the market is classified into neurostimulation devices, neurointerventional devices, neurosurgical navigation systems, cerebral spinal fluid (CSF) management devices, and others. On the basis of application, it is segregated into spinal cord stimulation, deep brain stimulation, and neuroendoscopy. Depending on end user, it is fragmented into hospitals, ambulatory surgical centers, and others. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Findings
By product, the neurostimulation devices segment held the market share in 2023.
On the basis of application, the deep brain stimulation segment dominated the market, in terms of share, in 2023.
Depending on end user, the hospital segment was the major shareholder in 2023.
Region wise, North America emerged as the most lucrative market for neurosurgery devices in 2023.
Competition Analysis
Competitive analysis and profiles of the major players in the global neurosurgery devices market include Abbott Laboratories, Ackermann Instrumente GmbH, Adeor Medical AG, B. Braun Melsungen AG, Biotronik SE & Co. KG, Boston Scientific Corporation, Johnson and Johnson, Integra Lifesciences Corporation., Medtronic Plc, and Stryker Corporation. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to sustain the intense competition and gain a strong foothold in the global market.
Additional benefits you will get with this purchase are:
- Quarterly Update and* (only available with a corporate license, on listed price)
- 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
- Free Upcoming Version on the Purchase of Five and Enterprise User License.
- 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
- 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
- Free data Pack on the Five and Enterprise User License. (Excel version of the report)
- Free Updated report if the report is 6-12 months old or older.
- 24-hour priority response*
- Free Industry updates and white papers.
Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)
- New Product Development/ Product Matrix of Key Players
- Regulatory Guidelines
- Additional company profiles with specific to client's interest
- Additional country or region analysis- market size and forecast
- Average Selling Price Analysis / Price Point Analysis
- Expanded list for Company Profiles
- Historic market data
Key Market Segments
By Product
- Neurostimulation Devices
- Neurointerventional Devices
- Neurosurgical Navigation Systems
- Cerebral Spinal Fluid (CSF) Management Devices
- Others
By Application
- Spinal Cord Stimulation
- Deep Brain Stimulation
- Neuroendoscopy
By End User
- Hospitals
- Ambulatory Surgical Centers
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
- Key Market Players
- Abbott Laboratories
- Ackermann Instrumente GmbH
- Adeor Medical AG
- B. Braun Melsungen AG
- Biotronik SE & Co. KG
- Boston Scientific Corporation
- Johnson and Johnson
- Integra Lifesciences Corporation.
- Medtronic plc
- Stryker Corporation.
CHAPTER 1: INTRODUCTION
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
3.3.1. Bargaining Power of Suppliers
3.3.2. Threat of New Entrants
3.3.3. Threat of Substitutes
3.3.4. Competitive Rivalry
3.3.5. Bargaining Power among Buyers
3.4. Market Dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
CHAPTER 4: NEUROSURGERY DEVICES MARKET, BY PRODUCT
4.1. Market Overview
4.1.1 Market Size and Forecast, By Product
4.2. Neurostimulation Devices
4.2.1. Key Market Trends, Growth Factors and Opportunities
4.2.2. Market Size and Forecast, By Region
4.2.3. Market Share Analysis, By Country
4.3. Neurointerventional Devices
4.3.1. Key Market Trends, Growth Factors and Opportunities
4.3.2. Market Size and Forecast, By Region
4.3.3. Market Share Analysis, By Country
4.4. Neurosurgical Navigation Systems
4.4.1. Key Market Trends, Growth Factors and Opportunities
4.4.2. Market Size and Forecast, By Region
4.4.3. Market Share Analysis, By Country
4.5. Cerebral Spinal Fluid (CSF) Management Devices
4.5.1. Key Market Trends, Growth Factors and Opportunities
4.5.2. Market Size and Forecast, By Region
4.5.3. Market Share Analysis, By Country
4.6. Others
4.6.1. Key Market Trends, Growth Factors and Opportunities
4.6.2. Market Size and Forecast, By Region
4.6.3. Market Share Analysis, By Country
CHAPTER 5: NEUROSURGERY DEVICES MARKET, BY APPLICATION
5.1. Market Overview
5.1.1 Market Size and Forecast, By Application
5.2. Spinal Cord Stimulation
5.2.1. Key Market Trends, Growth Factors and Opportunities
5.2.2. Market Size and Forecast, By Region
5.2.3. Market Share Analysis, By Country
5.3. Deep Brain Stimulation
5.3.1. Key Market Trends, Growth Factors and Opportunities
5.3.2. Market Size and Forecast, By Region
5.3.3. Market Share Analysis, By Country
5.4. Neuroendoscopy
5.4.1. Key Market Trends, Growth Factors and Opportunities
5.4.2. Market Size and Forecast, By Region
5.4.3. Market Share Analysis, By Country
CHAPTER 6: NEUROSURGERY DEVICES MARKET, BY END USER
6.1. Market Overview
6.1.1 Market Size and Forecast, By End User
6.2. Hospitals
6.2.1. Key Market Trends, Growth Factors and Opportunities
6.2.2. Market Size and Forecast, By Region
6.2.3. Market Share Analysis, By Country
6.3. Ambulatory Surgical Centers
6.3.1. Key Market Trends, Growth Factors and Opportunities
6.3.2. Market Size and Forecast, By Region
6.3.3. Market Share Analysis, By Country
6.4. Others
6.4.1. Key Market Trends, Growth Factors and Opportunities
6.4.2. Market Size and Forecast, By Region
6.4.3. Market Share Analysis, By Country
CHAPTER 7: NEUROSURGERY DEVICES MARKET, BY REGION
7.1. Market Overview
7.1.1 Market Size and Forecast, By Region
7.2. North America
7.2.1. Key Market Trends and Opportunities
7.2.2. Market Size and Forecast, By Product
7.2.3. Market Size and Forecast, By Application
7.2.4. Market Size and Forecast, By End User
7.2.5. Market Size and Forecast, By Country
7.2.6. U.S. Neurosurgery Devices Market
7.2.6.1. Market Size and Forecast, By Product
7.2.6.2. Market Size and Forecast, By Application
7.2.6.3. Market Size and Forecast, By End User
7.2.7. Canada Neurosurgery Devices Market
7.2.7.1. Market Size and Forecast, By Product
7.2.7.2. Market Size and Forecast, By Application
7.2.7.3. Market Size and Forecast, By End User
7.2.8. Mexico Neurosurgery Devices Market
7.2.8.1. Market Size and Forecast, By Product
7.2.8.2. Market Size and Forecast, By Application
7.2.8.3. Market Size and Forecast, By End User
7.3. Europe
7.3.1. Key Market Trends and Opportunities
7.3.2. Market Size and Forecast, By Product
7.3.3. Market Size and Forecast, By Application
7.3.4. Market Size and Forecast, By End User
7.3.5. Market Size and Forecast, By Country
7.3.6. Germany Neurosurgery Devices Market
7.3.6.1. Market Size and Forecast, By Product
7.3.6.2. Market Size and Forecast, By Application
7.3.6.3. Market Size and Forecast, By End User
7.3.7. France Neurosurgery Devices Market
7.3.7.1. Market Size and Forecast, By Product
7.3.7.2. Market Size and Forecast, By Application
7.3.7.3. Market Size and Forecast, By End User
7.3.8. UK Neurosurgery Devices Market
7.3.8.1. Market Size and Forecast, By Product
7.3.8.2. Market Size and Forecast, By Application
7.3.8.3. Market Size and Forecast, By End User
7.3.9. Italy Neurosurgery Devices Market
7.3.9.1. Market Size and Forecast, By Product
7.3.9.2. Market Size and Forecast, By Application
7.3.9.3. Market Size and Forecast, By End User
7.3.10. Spain Neurosurgery Devices Market
7.3.10.1. Market Size and Forecast, By Product
7.3.10.2. Market Size and Forecast, By Application
7.3.10.3. Market Size and Forecast, By End User
7.3.11. Rest Of Europe Neurosurgery Devices Market
7.3.11.1. Market Size and Forecast, By Product
7.3.11.2. Market Size and Forecast, By Application
7.3.11.3. Market Size and Forecast, By End User
7.4. Asia-Pacific
7.4.1. Key Market Trends and Opportunities
7.4.2. Market Size and Forecast, By Product
7.4.3. Market Size and Forecast, By Application
7.4.4. Market Size and Forecast, By End User
7.4.5. Market Size and Forecast, By Country
7.4.6. Japan Neurosurgery Devices Market
7.4.6.1. Market Size and Forecast, By Product
7.4.6.2. Market Size and Forecast, By Application
7.4.6.3. Market Size and Forecast, By End User
7.4.7. China Neurosurgery Devices Market
7.4.7.1. Market Size and Forecast, By Product
7.4.7.2. Market Size and Forecast, By Application
7.4.7.3. Market Size and Forecast, By End User
7.4.8. Australia Neurosurgery Devices Market
7.4.8.1. Market Size and Forecast, By Product
7.4.8.2. Market Size and Forecast, By Application
7.4.8.3. Market Size and Forecast, By End User
7.4.9. India Neurosurgery Devices Market
7.4.9.1. Market Size and Forecast, By Product
7.4.9.2. Market Size and Forecast, By Application
7.4.9.3. Market Size and Forecast, By End User
7.4.10. South Korea Neurosurgery Devices Market
7.4.10.1. Market Size and Forecast, By Product
7.4.10.2. Market Size and Forecast, By Application
7.4.10.3. Market Size and Forecast, By End User
7.4.11. Rest of Asia-Pacific Neurosurgery Devices Market
7.4.11.1. Market Size and Forecast, By Product
7.4.11.2. Market Size and Forecast, By Application
7.4.11.3. Market Size and Forecast, By End User
7.5. LAMEA
7.5.1. Key Market Trends and Opportunities
7.5.2. Market Size and Forecast, By Product
7.5.3. Market Size and Forecast, By Application
7.5.4. Market Size and Forecast, By End User
7.5.5. Market Size and Forecast, By Country
7.5.6. Brazil Neurosurgery Devices Market
7.5.6.1. Market Size and Forecast, By Product
7.5.6.2. Market Size and Forecast, By Application
7.5.6.3. Market Size and Forecast, By End User
7.5.7. Saudi Arabia Neurosurgery Devices Market
7.5.7.1. Market Size and Forecast, By Product
7.5.7.2. Market Size and Forecast, By Application
7.5.7.3. Market Size and Forecast, By End User
7.5.8. South Africa Neurosurgery Devices Market
7.5.8.1. Market Size and Forecast, By Product
7.5.8.2. Market Size and Forecast, By Application
7.5.8.3. Market Size and Forecast, By End User
7.5.9. Rest of LAMEA Neurosurgery Devices Market
7.5.9.1. Market Size and Forecast, By Product
7.5.9.2. Market Size and Forecast, By Application
7.5.9.3. Market Size and Forecast, By End User
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top Winning Strategies
8.3. Product Mapping Of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top Player Positioning, 2023
CHAPTER 9: COMPANY PROFILES
9.1. Abbott Laboratories
9.1.1. Company Overview
9.1.2. Key Executives
9.1.3. Company Snapshot
9.1.4. Operating Business Segments
9.1.5. Product Portfolio
9.1.6. Business Performance
9.1.7. Key Strategic Moves and Developments
9.2. Ackermann Instrumente GmbH
9.2.1. Company Overview
9.2.2. Key Executives
9.2.3. Company Snapshot
9.2.4. Operating Business Segments
9.2.5. Product Portfolio
9.2.6. Business Performance
9.2.7. Key Strategic Moves and Developments
9.3. Adeor Medical AG
9.3.1. Company Overview
9.3.2. Key Executives
9.3.3. Company Snapshot
9.3.4. Operating Business Segments
9.3.5. Product Portfolio
9.3.6. Business Performance
9.3.7. Key Strategic Moves and Developments
9.4. B. Braun Melsungen AG
9.4.1. Company Overview
9.4.2. Key Executives
9.4.3. Company Snapshot
9.4.4. Operating Business Segments
9.4.5. Product Portfolio
9.4.6. Business Performance
9.4.7. Key Strategic Moves and Developments
9.5. Biotronik SE And Co. KG
9.5.1. Company Overview
9.5.2. Key Executives
9.5.3. Company Snapshot
9.5.4. Operating Business Segments
9.5.5. Product Portfolio
9.5.6. Business Performance
9.5.7. Key Strategic Moves and Developments
9.6. Boston Scientific Corporation
9.6.1. Company Overview
9.6.2. Key Executives
9.6.3. Company Snapshot
9.6.4. Operating Business Segments
9.6.5. Product Portfolio
9.6.6. Business Performance
9.6.7. Key Strategic Moves and Developments
9.7. Johnson And Johnson
9.7.1. Company Overview
9.7.2. Key Executives
9.7.3. Company Snapshot
9.7.4. Operating Business Segments
9.7.5. Product Portfolio
9.7.6. Business Performance
9.7.7. Key Strategic Moves and Developments
9.8. Integra Lifesciences Corporation.
9.8.1. Company Overview
9.8.2. Key Executives
9.8.3. Company Snapshot
9.8.4. Operating Business Segments
9.8.5. Product Portfolio
9.8.6. Business Performance
9.8.7. Key Strategic Moves and Developments
9.9. Medtronic Plc
9.9.1. Company Overview
9.9.2. Key Executives
9.9.3. Company Snapshot
9.9.4. Operating Business Segments
9.9.5. Product Portfolio
9.9.6. Business Performance
9.9.7. Key Strategic Moves and Developments
9.10. Stryker Corporation.
9.10.1. Company Overview
9.10.2. Key Executives
9.10.3. Company Snapshot
9.10.4. Operating Business Segments
9.10.5. Product Portfolio
9.10.6. Business Performance
9.10.7. Key Strategic Moves and Developments
LIST OF TABLES
TABLE 1. GLOBAL NEUROSURGERY DEVICES MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 2. NEUROSURGERY DEVICES MARKET FOR NEUROSTIMULATION DEVICES, BY REGION, 2024 - 2033 ($BILLION)
TABLE 3. NEUROSURGERY DEVICES MARKET FOR NEUROINTERVENTIONAL DEVICES, BY REGION, 2024 - 2033 ($BILLION)
TABLE 4. NEUROSURGERY DEVICES MARKET FOR NEUROSURGICAL NAVIGATION SYSTEMS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 5. NEUROSURGERY DEVICES MARKET FOR CEREBRAL SPINAL FLUID (CSF) MANAGEMENT DEVICES, BY REGION, 2024 - 2033 ($BILLION)
TABLE 6. NEUROSURGERY DEVICES MARKET FOR OTHERS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 7. GLOBAL NEUROSURGERY DEVICES MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 8. NEUROSURGERY DEVICES MARKET FOR SPINAL CORD STIMULATION, BY REGION, 2024 - 2033 ($BILLION)
TABLE 9. NEUROSURGERY DEVICES MARKET FOR DEEP BRAIN STIMULATION, BY REGION, 2024 - 2033 ($BILLION)
TABLE 10. NEUROSURGERY DEVICES MARKET FOR NEUROENDOSCOPY, BY REGION, 2024 - 2033 ($BILLION)
TABLE 11. GLOBAL NEUROSURGERY DEVICES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 12. NEUROSURGERY DEVICES MARKET FOR HOSPITALS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 13. NEUROSURGERY DEVICES MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 14. NEUROSURGERY DEVICES MARKET FOR OTHERS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 15. NEUROSURGERY DEVICES MARKET, BY REGION, 2024 - 2033 ($BILLION)
TABLE 16. NORTH AMERICA NEUROSURGERY DEVICES MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 17. NORTH AMERICA NEUROSURGERY DEVICES MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 18. NORTH AMERICA NEUROSURGERY DEVICES MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 19. NORTH AMERICA NEUROSURGERY DEVICES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 20. U.S. NEUROSURGERY DEVICES MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 21. U.S. NEUROSURGERY DEVICES MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 22. U.S. NEUROSURGERY DEVICES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 23. CANADA NEUROSURGERY DEVICES MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 24. CANADA NEUROSURGERY DEVICES MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 25. CANADA NEUROSURGERY DEVICES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 26. MEXICO NEUROSURGERY DEVICES MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 27. MEXICO NEUROSURGERY DEVICES MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 28. MEXICO NEUROSURGERY DEVICES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 29. EUROPE NEUROSURGERY DEVICES MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 30. EUROPE NEUROSURGERY DEVICES MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 31. EUROPE NEUROSURGERY DEVICES MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 32. EUROPE NEUROSURGERY DEVICES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 33. GERMANY NEUROSURGERY DEVICES MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 34. GERMANY NEUROSURGERY DEVICES MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 35. GERMANY NEUROSURGERY DEVICES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 36. FRANCE NEUROSURGERY DEVICES MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 37. FRANCE NEUROSURGERY DEVICES MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 38. FRANCE NEUROSURGERY DEVICES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 39. UK NEUROSURGERY DEVICES MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 40. UK NEUROSURGERY DEVICES MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 41. UK NEUROSURGERY DEVICES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 42. ITALY NEUROSURGERY DEVICES MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 43. ITALY NEUROSURGERY DEVICES MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 44. ITALY NEUROSURGERY DEVICES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 45. SPAIN NEUROSURGERY DEVICES MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 46. SPAIN NEUROSURGERY DEVICES MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 47. SPAIN NEUROSURGERY DEVICES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 48. REST OF EUROPE NEUROSURGERY DEVICES MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 49. REST OF EUROPE NEUROSURGERY DEVICES MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 50. REST OF EUROPE NEUROSURGERY DEVICES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 51. ASIA-PACIFIC NEUROSURGERY DEVICES MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 52. ASIA-PACIFIC NEUROSURGERY DEVICES MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 53. ASIA-PACIFIC NEUROSURGERY DEVICES MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 54. ASIA-PACIFIC NEUROSURGERY DEVICES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 55. JAPAN NEUROSURGERY DEVICES MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 56. JAPAN NEUROSURGERY DEVICES MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 57. JAPAN NEUROSURGERY DEVICES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 58. CHINA NEUROSURGERY DEVICES MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 59. CHINA NEUROSURGERY DEVICES MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 60. CHINA NEUROSURGERY DEVICES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 61. AUSTRALIA NEUROSURGERY DEVICES MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 62. AUSTRALIA NEUROSURGERY DEVICES MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 63. AUSTRALIA NEUROSURGERY DEVICES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 64. INDIA NEUROSURGERY DEVICES MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 65. INDIA NEUROSURGERY DEVICES MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 66. INDIA NEUROSURGERY DEVICES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 67. SOUTH KOREA NEUROSURGERY DEVICES MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 68. SOUTH KOREA NEUROSURGERY DEVICES MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 69. SOUTH KOREA NEUROSURGERY DEVICES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 70. REST OF ASIA-PACIFIC NEUROSURGERY DEVICES MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 71. REST OF ASIA-PACIFIC NEUROSURGERY DEVICES MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 72. REST OF ASIA-PACIFIC NEUROSURGERY DEVICES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 73. LAMEA NEUROSURGERY DEVICES MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 74. LAMEA NEUROSURGERY DEVICES MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 75. LAMEA NEUROSURGERY DEVICES MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 76. LAMEA NEUROSURGERY DEVICES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 77. BRAZIL NEUROSURGERY DEVICES MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 78. BRAZIL NEUROSURGERY DEVICES MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 79. BRAZIL NEUROSURGERY DEVICES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 80. SAUDI ARABIA NEUROSURGERY DEVICES MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 81. SAUDI ARABIA NEUROSURGERY DEVICES MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 82. SAUDI ARABIA NEUROSURGERY DEVICES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 83. SOUTH AFRICA NEUROSURGERY DEVICES MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 84. SOUTH AFRICA NEUROSURGERY DEVICES MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 85. SOUTH AFRICA NEUROSURGERY DEVICES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 86. REST OF LAMEA NEUROSURGERY DEVICES MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 87. REST OF LAMEA NEUROSURGERY DEVICES MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 88. REST OF LAMEA NEUROSURGERY DEVICES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 89. ABBOTT LABORATORIES: KEY EXECUTIVES
TABLE 90. ABBOTT LABORATORIES: COMPANY SNAPSHOT
TABLE 91. ABBOTT LABORATORIES: OPERATING SEGMENTS
TABLE 92. ABBOTT LABORATORIES: PRODUCT PORTFOLIO
TABLE 93. ABBOTT LABORATORIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 94. ACKERMANN INSTRUMENTE GMBH: KEY EXECUTIVES
TABLE 95. ACKERMANN INSTRUMENTE GMBH: COMPANY SNAPSHOT
TABLE 96. ACKERMANN INSTRUMENTE GMBH: OPERATING SEGMENTS
TABLE 97. ACKERMANN INSTRUMENTE GMBH: PRODUCT PORTFOLIO
TABLE 98. ACKERMANN INSTRUMENTE GMBH: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 99. ADEOR MEDICAL AG: KEY EXECUTIVES
TABLE 100. ADEOR MEDICAL AG: COMPANY SNAPSHOT
TABLE 101. ADEOR MEDICAL AG: OPERATING SEGMENTS
TABLE 102. ADEOR MEDICAL AG: PRODUCT PORTFOLIO
TABLE 103. ADEOR MEDICAL AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 104. B. BRAUN MELSUNGEN AG: KEY EXECUTIVES
TABLE 105. B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT
TABLE 106. B. BRAUN MELSUNGEN AG: OPERATING SEGMENTS
TABLE 107. B. BRAUN MELSUNGEN AG: PRODUCT PORTFOLIO
TABLE 108. B. BRAUN MELSUNGEN AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 109. BIOTRONIK SE AND CO. KG: KEY EXECUTIVES
TABLE 110. BIOTRONIK SE AND CO. KG: COMPANY SNAPSHOT
TABLE 111. BIOTRONIK SE AND CO. KG: OPERATING SEGMENTS
TABLE 112. BIOTRONIK SE AND CO. KG: PRODUCT PORTFOLIO
TABLE 113. BIOTRONIK SE AND CO. KG: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 114. BOSTON SCIENTIFIC CORPORATION: KEY EXECUTIVES
TABLE 115. BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
TABLE 116. BOSTON SCIENTIFIC CORPORATION: OPERATING SEGMENTS
TABLE 117. BOSTON SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO
TABLE 118. BOSTON SCIENTIFIC CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 119. JOHNSON AND JOHNSON: KEY EXECUTIVES
TABLE 120. JOHNSON AND JOHNSON: COMPANY SNAPSHOT
TABLE 121. JOHNSON AND JOHNSON: OPERATING SEGMENTS
TABLE 122. JOHNSON AND JOHNSON: PRODUCT PORTFOLIO
TABLE 123. JOHNSON AND JOHNSON: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 124. INTEGRA LIFESCIENCES CORPORATION.: KEY EXECUTIVES
TABLE 125. INTEGRA LIFESCIENCES CORPORATION.: COMPANY SNAPSHOT
TABLE 126. INTEGRA LIFESCIENCES CORPORATION.: OPERATING SEGMENTS
TABLE 127. INTEGRA LIFESCIENCES CORPORATION.: PRODUCT PORTFOLIO
TABLE 128. INTEGRA LIFESCIENCES CORPORATION.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 129. MEDTRONIC PLC: KEY EXECUTIVES
TABLE 130. MEDTRONIC PLC: COMPANY SNAPSHOT
TABLE 131. MEDTRONIC PLC: OPERATING SEGMENTS
TABLE 132. MEDTRONIC PLC: PRODUCT PORTFOLIO
TABLE 133. MEDTRONIC PLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 134. STRYKER CORPORATION.: KEY EXECUTIVES
TABLE 135. STRYKER CORPORATION.: COMPANY SNAPSHOT
TABLE 136. STRYKER CORPORATION.: OPERATING SEGMENTS
TABLE 137. STRYKER CORPORATION.: PRODUCT PORTFOLIO
TABLE 138. STRYKER CORPORATION.: KEY STRATEGIC MOVES AND DEVELOPMENTS
LIST OF FIGURES
FIGURE 1. GLOBAL NEUROSURGERY DEVICES MARKET, 2024 - 2033
FIGURE 2. SEGMENTATION OF NEUROSURGERY DEVICES MARKET, 2024 - 2033
FIGURE 3. TOP INVESTMENT POCKET IN NEUROSURGERY DEVICES MARKET
FIGURE 4. MODERATE BARGAINING POWER OF BUYERS
FIGURE 5. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 6. MODERATE THREAT OF NEW ENTRANTS
FIGURE 7. LOW THREAT OF SUBSTITUTION
FIGURE 8. HIGH COMPETITIVE RIVALRY
FIGURE 9. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALNEUROSURGERY DEVICES MARKET
FIGURE 10. GLOBAL NEUROSURGERY DEVICES MARKET SEGMENTATION, BY PRODUCT
FIGURE 11. NEUROSURGERY DEVICES MARKET FOR NEUROSTIMULATION DEVICES, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 12. NEUROSURGERY DEVICES MARKET FOR NEUROINTERVENTIONAL DEVICES, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 13. NEUROSURGERY DEVICES MARKET FOR NEUROSURGICAL NAVIGATION SYSTEMS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 14. NEUROSURGERY DEVICES MARKET FOR CEREBRAL SPINAL FLUID (CSF) MANAGEMENT DEVICES, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 15. NEUROSURGERY DEVICES MARKET FOR OTHERS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 16. GLOBAL NEUROSURGERY DEVICES MARKET SEGMENTATION, BY APPLICATION
FIGURE 17. NEUROSURGERY DEVICES MARKET FOR SPINAL CORD STIMULATION, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 18. NEUROSURGERY DEVICES MARKET FOR DEEP BRAIN STIMULATION, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 19. NEUROSURGERY DEVICES MARKET FOR NEUROENDOSCOPY, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 20. GLOBAL NEUROSURGERY DEVICES MARKET SEGMENTATION, BY END USER
FIGURE 21. NEUROSURGERY DEVICES MARKET FOR HOSPITALS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 22. NEUROSURGERY DEVICES MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 23. NEUROSURGERY DEVICES MARKET FOR OTHERS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 24. TOP WINNING STRATEGIES, BY YEAR, 2021-2023*
FIGURE 25. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2021-2023*
FIGURE 26. TOP WINNING STRATEGIES, BY COMPANY, 2021-2023*
FIGURE 27. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 28. COMPETITIVE DASHBOARD
FIGURE 29. COMPETITIVE HEATMAP: NEUROSURGERY DEVICES MARKET
FIGURE 30. TOP PLAYER POSITIONING, 2023
FIGURE 31. ABBOTT LABORATORIES: NET SALES, 2021-2023 ($BILLION)
FIGURE 32. ABBOTT LABORATORIES: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 33. ABBOTT LABORATORIES: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 34. ACKERMANN INSTRUMENTE GMBH: NET SALES, 2021-2023 ($BILLION)
FIGURE 35. ACKERMANN INSTRUMENTE GMBH: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 36. ACKERMANN INSTRUMENTE GMBH: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 37. ADEOR MEDICAL AG: NET SALES, 2021-2023 ($BILLION)
FIGURE 38. ADEOR MEDICAL AG: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 39. ADEOR MEDICAL AG: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 40. B. BRAUN MELSUNGEN AG: NET SALES, 2021-2023 ($BILLION)
FIGURE 41. B. BRAUN MELSUNGEN AG: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 42. B. BRAUN MELSUNGEN AG: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 43. BIOTRONIK SE AND CO. KG: NET SALES, 2021-2023 ($BILLION)
FIGURE 44. BIOTRONIK SE AND CO. KG: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 45. BIOTRONIK SE AND CO. KG: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 46. BOSTON SCIENTIFIC CORPORATION: NET SALES, 2021-2023 ($BILLION)
FIGURE 47. BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 48. BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 49. JOHNSON AND JOHNSON: NET SALES, 2021-2023 ($BILLION)
FIGURE 50. JOHNSON AND JOHNSON: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 51. JOHNSON AND JOHNSON: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 52. INTEGRA LIFESCIENCES CORPORATION.: NET SALES, 2021-2023 ($BILLION)
FIGURE 53. INTEGRA LIFESCIENCES CORPORATION.: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 54. INTEGRA LIFESCIENCES CORPORATION.: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 55. MEDTRONIC PLC: NET SALES, 2021-2023 ($BILLION)
FIGURE 56. MEDTRONIC PLC: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 57. MEDTRONIC PLC: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 58. STRYKER CORPORATION.: NET SALES, 2021-2023 ($BILLION)
FIGURE 59. STRYKER CORPORATION.: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 60. STRYKER CORPORATION.: REVENUE SHARE, BY REGION, 2023 (%)
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security